This announcement is a separate document:
北京德恒律师事务所关于浙江圣达生物药业股份有限公司2023年度向特定对象发行A股股票的补充法律意见书（三）
Beijing Deheng Law Firm\'s Supplementary Legal Opinion on Zhejiang Shengda Biopharmaceutical Co., Ltd.\'s issuance of A-shares to specific targets in 2023 (3)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated